Aquaporin water channels affect the response of conventional anticancer therapies of 3D grown breast cancer cells.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
08 01 2023
Historique:
received: 15 11 2022
revised: 21 11 2022
accepted: 29 11 2022
pubmed: 9 12 2022
medline: 4 1 2023
entrez: 8 12 2022
Statut: ppublish

Résumé

Aquaporin (AQP) water channels facilitate water transport across cellular membranes and are essential in regulation of body water balance. Moreover, several AQPs are overexpressed or ectopically expressed in breast cancer. Interestingly, several in vitro studies have suggested that AQPs can affect the response to conventional anticancer chemotherapies. Therefore, we took a systematic approach to test how AQP1, AQP3 and AQP5, which are often over-/ectopically expressed in breast cancer, affect total viability of 3-dimensional (3D) breast cancer cell spheroids when treated with the conventional anticancer chemotherapies Cisplatin, 5-Fluorouracil (5-FU) and Doxorubicin, a Combination of the three drugs as well as the Combination plus the Ras inhibitor Salirasib. Total viability of spheroids overexpressing AQP1 were decreased by all treatments except for 5-FU, which increased total viability by 20% compared to DMSO treated controls. All treatments reduced viability of spheroids overexpressing AQP3. In contrast, only Doxorubicin, Combination and Combination + Salirasib reduced total viability of spheroids overexpressing AQP5. Thus, this study supports a significant role of AQPs in the response to conventional chemotherapies. Evaluating the role of individual proteins that contribute to resistance to chemotherapies is essential in advancing personalized medicine in breast carcinomas.

Identifiants

pubmed: 36481356
pii: S0006-291X(22)01653-9
doi: 10.1016/j.bbrc.2022.11.096
pii:
doi:

Substances chimiques

farnesylthiosalicylic acid 0
Aquaporins 0
Fluorouracil U3P01618RT
Doxorubicin 80168379AG
Aquaporin 1 146410-94-8
Aquaporin 5 0
Aquaporin 3 158801-98-0
Aquaporin 4 0
Aquaporin 2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-133

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Sarannya Edamana (S)

Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark.

Stine F Pedersen (SF)

Department of Biology, Section for Cell Biology and Physiology, University of Copenhagen, Universitetsparken 13, 2100, København Ø, Denmark.

Lene N Nejsum (LN)

Department of Clinical Medicine, Aarhus University, 8200, Aarhus N, Denmark. Electronic address: nejsum@clin.au.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH